BioSpace News Archive

BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the fourth quarter and full year ended December 31, 2021.

Torres brings top tech global marketing and brand strategy experience to help the company with its mission to transform care technology.

Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2021 results.

Global Cord Blood Corporation (NYSE: CO) (the “Company”), today announced that it plans to release its financial results for the third quarter and first nine months of fiscal 2022 on Monday, February 28, 2022, after the U.S. market close.

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), today announced that Duncan Peyton, Chief Executive Officer, and Alex Stevenson, Chief Scientific Officer of 4D pharma, will participate in a fireside chat at the Chardan Metagenomics and Microbiome Medicines Summit on Tuesday, March 1, 2022 at 9:00 a.m. ET (2:00 p.m. GMT).

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company” or “we”) today announced its fourth-quarter and full-year 2021 financial results.

The Board of Directors of Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and industrial solutions, declared on February 22 a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 24, 2022 to stockholders of record on March 9, 2022.

Cytokinetics, Incorporated today announced that SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM), a Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), is open to enrollment.

KemPharm Positioned to Submit IND Application for KP1077 for Idiopathic Hypersomnia by Mid-2022.

Nicox SA, an international ophthalmology company, provides an update on the approvals and launches of VYZULTA, 0.024%, exclusively licensed worldwide by Nicox to Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc.